Daré Bioscience, Inc.

DARE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4-$4-$4-$6
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$2-$2-$2$10
Other Non-Cash$1$0$0$0
Operating Cash Flow-$0-$5-$5$5
Investing Activities
PP&E Inv.-$0$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$0-$0-$1
Financing Activities
Debt Repay.-$0-$1-$0-$0
Stock Issued$19$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$0-$0
Financing Cash Flow$19-$0$0-$0
Forex Effect$0$0$0-$0
Net Chg. in Cash$18-$5-$5$4
Supplemental Information
Beg. Cash$5$11$16$12
End Cash$23$5$11$16
Free Cash Flow-$1-$5-$6$5